Consonance Capital Management LP Chemo Centryx, Inc. Transaction History

Consonance Capital Management LP

$7.28 Million
Q3 2022

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 16, 2020	SELL	$46.35 - $61.69 $79.1 Million - $105 Million	-1,706,426 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$38.58 - $65.07 $22.8 Million - $38.5 Million	-591,353 Reduced 25.74%	1,706,426 $98.2 Million
Q1 2020 May 15, 2020	BUY	$32.73 - $50.78 $13 Million - $20.1 Million	396,112 Added 20.83%	2,297,779 $92.3 Million
Q4 2019 Feb 14, 2020	BUY	$6.81 - $39.55 $1.6 Million - $9.29 Million	235,000 Added 14.1%	1,901,667 $75.2 Million
Q1 2019 May 15, 2019	BUY	$10.01 - $13.89 $16.7 Million - $23.2 Million	1,666,667 New	1,666,667 $23.2 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.